Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-06-01 Sale |
2023-06-01 4:29 pm |
TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer |
109,459 | $0 | $0 | 0 (Direct) |
View |
2022-12-09 Sale |
2022-12-13 8:26 pm |
TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer |
13,799 | $1.0959 | $15,123 | 232,717 (Direct) |
View |
2022-12-07 Sale |
2022-12-09 4:53 pm |
TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer |
7,942 | $1.2694 | $10,081 | 254,458 (Direct) |
View |
2022-12-05 Sale |
2022-12-07 7:56 pm |
TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer |
7,464 | $1.3518 | $10,090 | 269,864 (Direct) |
View |
2022-12-02 Sale |
2022-12-05 7:52 pm |
TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer |
3,636 | $1.39 | $5,054 | 203,026 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-22 Option Award |
2025-01-24 4:16 pm |
N/A 2035-01-21 |
Foghorn Therapeutics Inc. | FHTX | Cardama Alfonso Quintas Chief Medical Officer |
125,000 | $4.37 | 125,000 (Direct) |
View |
2024-01-24 Option Award |
2024-01-25 4:04 pm |
N/A 2034-01-23 |
Foghorn Therapeutics Inc. | FHTX | Cardama Alfonso Quintas Chief Medical Officer |
60,000 | $3.06 | 60,000 (Direct) |
View |
2023-09-11 Option Award |
2023-09-13 4:01 pm |
N/A 2033-09-10 |
Foghorn Therapeutics Inc. | FHTX | Cardama Alfonso Quintas Chief Medical Officer |
272,000 | $7.57 | 272,000 (Direct) |
View |
2022-12-15 Option Award |
2022-12-19 5:44 pm |
N/A 2032-12-14 |
TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer |
82,424 | $0 | 191,883 (Direct) |
View |
2022-12-01 Exercise |
2022-12-05 7:52 pm |
N/A N/A |
TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer |
190,770 | $0 | 203,026 (Direct) |
View |
2022-11-17 Option Award |
2022-11-18 4:38 pm |
N/A N/A |
TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer |
112,832 | $0 | 159,747 (Direct) |
View |
2021-12-09 Option Award |
2021-12-10 4:34 pm |
N/A 2031-12-08 |
TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer |
114,700 | $0 | 193,197 (Direct) |
View |
2021-08-31 Option Award |
2021-12-10 4:34 pm |
N/A N/A |
TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer |
164 | $14.26 | 193,197 (Direct) |
View |
2021-12-09 Exercise |
2021-12-10 4:34 pm |
N/A 2027-10-09 |
TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer |
43,000 | $0.74 | 193,197 (Direct) |
View |
2021-02-28 Option Award |
2021-03-08 08:20 am |
N/A N/A |
TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer |
708 | $16.12 | 3,751 (Direct) |
View |
2020-08-31 Option Award |
2021-03-08 08:20 am |
N/A N/A |
TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer |
1,118 | $10.1 | 3,751 (Direct) |
View |
2020-12-10 Option Award |
2020-12-11 06:19 am |
N/A 2030-12-09 |
TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer |
101,000 | $0 | 102,925 (Direct) |
View |